These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7664058)

  • 1. A mechanism for heparin-induced potentiation of antithrombin III.
    van Boeckel CA; Grootenhuis PD; Visser A
    Nat Struct Biol; 1994 Jul; 1(7):423-5. PubMed ID: 7664058
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformation of heparin pentasaccharide bound to antithrombin III.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Petitou M; Casu B
    Biochem J; 2001 Oct; 359(Pt 2):265-72. PubMed ID: 11583572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
    Petitou M; Lormeau JC; Choay J
    Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin.
    Sisu E; Tripathy S; Mallet JM; Driguez PA; Hérault JP; Sizun P; Herbert JM; Petitou M; Sinay P
    Biochimie; 2003; 85(1-2):91-9. PubMed ID: 12765779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation.
    Petitou M; Barzu T; Herault JP; Herbert JM
    Glycobiology; 1997 Apr; 7(3):323-7. PubMed ID: 9147040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-III.
    Ragazzi M; Ferro DR; Perly B; Torri G; Casu B; Sinaÿ P; Petitou M; Choay J
    Carbohydr Res; 1987 Jul; 165(1):c1-5. PubMed ID: 3664518
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
    Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
    Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How serpins are shaping up.
    Carrell RW
    Science; 1999 Sep; 285(5435):1861. PubMed ID: 10515791
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
    Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
    Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide model for the heparin binding site of antithrombin III.
    Lellouch AC; Lansbury PT
    Biochemistry; 1992 Mar; 31(8):2279-85. PubMed ID: 1540583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
    Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structures and biological activities of heparin-like molecules].
    Itano N; Okayama M
    Seikagaku; 1992 Jul; 64(7):513-20. PubMed ID: 1402210
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.